When does Charles River Laboratories report earnings?

Charles River Laboratories International, Inc. · end-of-day data as of Nov 13, 2026

Charles River Laboratories

CRL · $16.19B

$337.97-0.8%

Nov 13, 2026 · close

▲ 3

ConsensusBuy · 17
MAs3 of 4
Sector▲ +15.9%

Neutral

Earnings in96d
P/E371.4x
RSI52
Support-7.7%
Off 52w high-11.0%
Volume0.6x
Bollingerlower half
News0.00
FCF yield+2.5%
Trendsideways
52w range$146–$380
ATR+4.9%
Off ATH-26.6%

▼ 5

PT$325.42 -3.7%
P/E vs own+15.4%
P/E vs sector+1,052.9%
Insiders-$20.29M
MACD-2.80

Updates with the 15-min delayed price. Not a forecast or investment advice.

Charles River Laboratories CRL reports its next earnings on Wednesday, Feb 17, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $3.32 on revenue of $970M. Charles River Laboratories beat the EPS estimate in 8 of its last 8 reports, and the stock moved ±7.6% on average the session after. The last report, on Nov 4, 2026: EPS of $3.09 against $2.97 expected and revenue of $983M against $960M; the stock fell 7.3% the next session.

The stock around its reports

Last close $337.97 · +53.1% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue -2.2% year over year, free cash flow 21.1% of revenue, operating margin 20.6%.

RevenueFree cash flow


Q3 FY2026	Sep 26, 2026	$983M	6.86	$207M	36.4%	20.6%	33.9%
Q2 FY2026	Jun 27, 2026	$1B	-0.03	$149M	36.2%	11.9%	-0.1%
Q1 FY2026	Mar 28, 2026	$996M	-0.30	-$14.83M	28.0%	12.0%	-1.5%
Q4 FY2025	Dec 27, 2025	$994M	-5.62	$58.57M	31.0%	12.1%	-27.8%
Q3 FY2025	Sep 27, 2025	$1B	1.10	$178M	33.7%	13.3%	5.4%
Q2 FY2025	Jun 28, 2025	$1.03B	1.06	$169M	34.6%	9.7%	5.1%
Q1 FY2025	Mar 29, 2025	$984M	0.50	$112M	32.3%	7.6%	2.6%
Q4 FY2024	Dec 31, 2024	$1B	-4.22	$83.75M	28.4%	-16.7%	-21.5%